| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2849625 | American Heart Journal | 2010 | 9 Pages |
Abstract
STABILITY will assess whether direct inhibition of Lp-PLA2 with darapladib added to the standard of care confers clinical benefit to patients with CHD.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Harvey DSc, FCSANZ, Claes MD, PhD, Ralph MD, FCSANZ, David MSc, Robert MD, FACC, Andrzej MD, FESC, Ph. Gabriel MD, Christopher P. MD, Susan BSN, MSCE, Janet PhD, Trupti PhD, Elizabeth MD, FACC, Lars MD,